{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:55:51Z","timestamp":1789998951410,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4445,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1046\/j.1523-1747.2003.12494.x","type":"journal-article","created":{"date-parts":[[2003,9,26]],"date-time":"2003-09-26T15:09:28Z","timestamp":1064588968000},"page":"765-770","source":"Crossref","is-referenced-by-count":20,"title":["Autoantibodies in Vitiligo Patients Recognize Multiple Domains of the Melanin-Concentrating Hormone Receptor"],"prefix":"10.1016","volume":"121","author":[{"given":"Raju V.S.R.K.","family":"Gottumukkala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Waterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Herd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip F.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Weetman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Helen Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Gawkrodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0010","series-title":"Clin Exp Immunol","first-page":"38","article-title":"IgG antibodies from patients with primary Sj\u00f6gren's syndrome and systemic lupus erythematosus recognise different epitopes in 60-kD SSA\/Ro protein","author":"Barakat","year":"1992"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/1523-1747.ep12555773","article-title":"Identification of pigment cell antigens defined by vitiligo antibodies","volume":"98","author":"Cui","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0749.1995.tb00774.x","article-title":"Characterisation of vitiligo antigens","volume":"8","author":"Cui","year":"1995","journal-title":"Pigment Cell Res"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","article-title":"In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo","volume":"105","author":"Gilhar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0030","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0035","doi-asserted-by":"crossref","first-page":"35390","DOI":"10.1074\/jbc.M102391200","article-title":"The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I","volume":"276","author":"Hedstrand","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02786398","article-title":"Myasthenia gravis as a prototype autoimmune receptor disease","volume":"16","author":"Hoedemaekers","year":"1997","journal-title":"Immunol Res"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0045","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0006-291X(02)00932-4","article-title":"Melanin-concentrating hormone and its receptor are expressed and functional in human skin","volume":"296","author":"Hoogduijn","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","article-title":"Detection of tyrosinase autoantibodies in vitiligo patients using 35S-labelled recombinant human tyrosinase in a radioimmunoassay","volume":"109","author":"Kemp","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0055","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","article-title":"Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay","volume":"139","author":"Kemp","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","article-title":"Autoantibodies to human melanocyte-specific protein Pmel17 in the sera of vitiligo patients: A sensitive and quantitative radioimmunoassay (RIA)","volume":"114","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1523-1747.1999.00664.x","article-title":"Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo","volume":"113","author":"Kemp","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0070","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo","volume":"109","author":"Kemp","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(96)01160-X","article-title":"Characterisation of a human gene related to genes encoding somatostatin receptors","volume":"398","author":"Kolakowski","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0080","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.4049\/jimmunol.157.6.2707","article-title":"Auto-antibodies in insulin-dependent diabetes recognise distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen","volume":"157","author":"Lampasona","year":"1996","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0085","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J Invest Derma-tol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/mol.58.1.217","article-title":"Molecular characterisation of the melanin-concentrating hormone\/receptor complex: Identification of critical residues involved in binding and activation","volume":"58","author":"MacDonald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0095","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/thy.1999.9.467","article-title":"Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: A comparison to radioreceptor assay and thyroid stimulating bioassay","volume":"9","author":"Morgenthaler","year":"1999","journal-title":"Thyroid"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0100","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.4049\/jimmunol.161.12.6963","article-title":"Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes","volume":"161","author":"Naserke","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","article-title":"Antibodies to normal human melanocytes in vitiligo","volume":"158","author":"Naughton","year":"1983","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0110","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0190-9622(86)70260-0","article-title":"Correlation between vitiligo antibodies and extent of depigmentation in vitiligo","volume":"15","author":"Naughton","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0115","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: Patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0120","doi-asserted-by":"crossref","first-page":"935","DOI":"10.7326\/0003-4819-71-5-935","article-title":"Vitiligo in Graves' disease","volume":"71","author":"Ochi","year":"1969","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0125","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0135","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: The role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0140","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1021\/bi00367a013","article-title":"New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites","volume":"25","author":"Parker","year":"1986","journal-title":"Biochemistry"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00464702","article-title":"Methods of epitope mapping","volume":"16","author":"Petterson","year":"1992","journal-title":"Mol Biol Rep"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0150","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0155","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","article-title":"The role of tyrosinase in autoimmune vitiligo","volume":"344","author":"Song","year":"1994","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0160","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.4049\/jimmunol.157.11.5208","article-title":"Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase","volume":"157","author":"Syren","year":"1996","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0165","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI200114235","article-title":"Mechanisms for the induction of autoimmunity by infectious agents","volume":"108","author":"Wucherpfennig","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1747.2003.12494.x_bb0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2249.1992.tb06417.x","article-title":"Use of recombinant epitopes to study the heterogeneous nature of the autoantibodies against thyroid peroxidase in autoimmune thyroid disease","volume":"87","author":"Zanelli","year":"1992","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15304371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15304371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T21:23:45Z","timestamp":1704921825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15304371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0022202X15304371"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2003.12494.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}